|
|
Margaret A Chesney
Ph.D.
|
| Academic Title:
Professor |
| Primary Appointment:
Medicine |
| Secondary Appointments:
Family & Community Medicine |
| Additional Title(s):
Associate Director, Center for Integrative Medicine |
|
mchesney@compmed.umm.edu |
| Location:
Kernan Hospital, 2200 Kernan Drive,
Baltimore, MD 21207-6697 |
| Phone:
(410) 448-6871 |
| Fax:
(410) 448-6875 |
|
Personal History
BACKGROUND
Margaret A. Chesney is Professor in the Department of Medicine and the first Associate Director of the University of Maryland Center for Integrative Medicine. Prior to joining the Center in 2008, Dr. Chesney was the first Deputy Director of the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH). During her five years at NCCAM, Dr. Chesney also served as the Director of the Division of Extramural Research and Training. Also, while at NIH, she was the Senior Advisor to the Director of the Office of Behavioral and Social Sciences Research at NIH. Prior to taking the position at NIH, she was Professor of Medicine at the School of Medicine, University of California, San Francisco.
In her research, she has been engaged in clinical investigations in the area of behavorial and integrative medicine. The focus of her work has been the role of the individual in the promotion of personal health, prevention of disease, and the potential for optimal management of health across the lifespan. Much of her research has underscored the role that lifestyle and behavior can play in health, including work on the development and evaluation of behavioral strategies to enhance health and wellbeing, even in the face of serious health challenges from diseases such as cardiovascular disease and HIV/AIDS.
She has been President of the Academy of Behavioral Medicine Research, as well as President of the American Psychosomatic Society and President of the Division of Health Psychology of the American Psychological Association. She received the Annual Award for Outstanding Contributions to the APA Division of Health Psychology in 1982 and 1986, the President's Award from the Academy of Behavioral Medicine Research in 1987, the Charles C. Shepard Science Award, from the Centers for Disease Control and Prevention in 1999, and the Director's Award for work in Mind-Body Medicine from the Director of the National Center for Complementary and Alternative Medicine in 2005. In 2000, she was a Senior Fellow at the Center for the Advancement of Health in Washington DC, supported by the Robert Wood Johnson and John D. and Catherine T. MacArthur Foundations. In 2001, she was elected to the Institute of Medicine.
ADVISORY POSITIONS
Chair & Co-Chair
• Co-Chair, Meditation for Health Purposes, NIH Conference, July, 2008
• Chair, UCSF Selection Committee for the George Sarlo Award for Excellence in Mentoring, 1999-2003
• Co-Chair, Recruitment, Adherence, Retention Committee, AIDS Clinical Trials Group, NIH, 1995-2001
• Co-Chair, Special Ad Hoc Working Group on the Women's Health Initiative of the Advisory Committee on Research on Women's Health, NIH, 1996-199
• Chair, Primary HIV Infection Workshop, Office of AIDS Research, 1996
• Chair, Working Group of Psychosocial Factors in AIDS Clinical Trials and Vaccine Trials, NIMH, 1994-1996
• Chair, Behavioral Risk Factor Interventions for the Prevention and Management of Disease, Task Force on Behavioral Research in Cardiovascular, Lung, and Blood Health and Disease, NHLBI, 1996
• Task Force on Psychosocial Factors in CVD Etiology in Women, Conference on Women, Behavior and CVD, NHLBI, 1992
• Working Conference on Adherence in Clinical Trials, Center for AIDS Research, AIDS Clinical Trials Group, NIMH, 1991
• Clinical Applications and Prevention Advisory Committee, NHLBI, 1986-1987
• Workshop on Ambulatory Monitoring of Blood Pressure, NHLBI, 1985
• Policy Planning and Data Monitoring Advisory Group for Biobehavioral Therapies of Hypertension, NHLBI, l984
• Working Conference on Assessment, Physiological Correlates, and Treatment of Anger, NIMH/NHLBI, l983
Member
• RWJ Health Policy Fellowships Program Advisory Board, Institute of Medicine, National Academy of Sciences, 2002- 2006
• Deputy Director Search Committee, National Institute on Aging, National Institutes of Health, 2001
• Advisory Committee, Fogarty International Center, National Institutes of Health, 1998-2001
• Committee on Future Directions for Behavioral and Social Science Research at the National Institutes of Health, National Academy of Sciences, 1998-2001
• Working Group on Bio-behavioral-social Perspectives on Health, NIH Office of Behavioral and Social Sciences Research and the Social Sciences Center, 1998-2001
• Institute of Medicine Committee on Health and Behavior: Research, Practice and Policy, 1998-2001
• Institute of Medicine and National Academy of Sciences Board of Neurosciences and Health, 1997- 2000
• Center for the Advancement of Health: Health and Behavior Alliance, 1996-2001
• Advisory Committee, Project MANIF, ANRS, INSERM, Marseilles, France, 1996-2001
• Technology Transfer Conference, NIMH, 1996
• Strategic Planning in Behavioral and Social Sciences, Office of Behavioral and Social Science Research, NIH, 1996
• NIH AIDS Research Program Evaluation, 1996
• Testing and Counseling: New Technologies and Prevention, Centers for Disease Control, 1996
• Research Workshop on AIDS and Stigma, NIMH, 1996
• AIDS Program Planning Task Force, UCSF, 1996
• Institute of Medicine Workshop on the Social and Behavioral Science Base for HIV/AIDS Prevention and Intervention, 1995
• Tuberculosis and Behavior: National Workshop on Research for the 21st Century, 1994
• Workshop on HIV/AIDS/TB, NIMH, 1994
• Disease Prevention Research at NIH: An Agenda for All, NIH, 1993
• Working Conference on Frontiers in Behavioral Medicine, NIH, 1993
• University-Wide Task Force on HIV Disease, State of California, 1993-Present
• National Task Force for the NIH Strategic Plan, 1992
• Working Conference on Women and Cardiovascular Disease, 1992
• Health and Behavior Study Section, NIMH, 1992 – 1995
• Advisory Committee, National Blood Resources Education Program, 1988 – Present
• National Heart, Lung, and Blood Institute Advisory Panel on AIDS Research, 1987 – 2001
• Working Group on Behavioral Interventions for Hypertension, National Heart, Lung, and Blood Institute, 1988 – 1992
• Working Conference on Theoretical Models in AIDS Research, 1991
• Working Conference on Contributions to Behavioral Medicine and Health Psychology from AIDS Research, NIMH, 1991
• Working Conference on Behavioral Factors in Treatment of Essential Hypertension, NHLBI, 1988
• Working Conference on the Assessment of Quality of Life in Clinical Trials, NHLBI, 1988
• Working Conference on Women and AIDS, NIMH and National Institute of Drug Abuse, 1987
• Working Conference on the Recognition and Management of Coronary Heart Disease in the Elderly, NHLBI, 1985
• Clinical Applications Prevention Advisory Committee, NHLBI, 1983-1986
• Planning Committee, American Heart Association Conference on Behavioral Medicine and Cardiovascular Disease, 1984-1985
• Working Conference on Behavioral Evaluation for the Systolic Hypertension in the Elderly Program, NHLBI, 1984
• Working Conference on Stress, Reactivity and Cardiovascular Disease, NHLBI, 1984
• Working Conference on Assessment of Quality of Life in Clinical Trails, NHLBI, 1983
• Working Conference on Measuring Psychosocial Variables in Epidemiological Studies of Cardiovascular Disease, NHLBI, 1983
• Working Conference on Experimental Design and Research Methodology in Behavioral Medicine, NHLBI, 1982-1983
• USSR/USA Scientific Exchange Delegation for Biobehavioral Approaches to the Development, Treatment, and Prevention of Hypertension, 1982, 1985, 1987, 1988
• Psychopathology and Clinical Biology Study Section, NIMH, 1979-1985
• Working Conference on Cardiovascular Instrumentation: Applicability of New Technology to Biobehavioral Research, NHLBI, 1982
• Hypertension Detection and Follow-up Program Working Group on Treatment of Mild Hypertension, NHLBI, 1981
• Behavioral Medicine Task Group, 10-Year Review and Update of the National Program Plan, NHLBI, 1981
• Working Group on Smoking Behavior, National Cancer Institute, 1981.
HONORS
• 2008: Honorary Doctorate in Humanities, Whitman College, Walla Walla Washington
• 2005: Director's Award, National Center for Complementary and Alternative Medicine, National Institutes of Health
• 2004: Alumnus of the Year, College of Natural Sciences, Colorado State University
• 2001: Elected Member, Institute of Medicine
• 2000: Senior Fellow, Center for the Advancement of Health
• 1999: Charles C. Shepard Science Award, Centers for Disease Control and Prevention
• 1987: President's Award, Academy of Behavioral Medicine Research
• 1987: Alumni of Merit Award, Whitman College
• 1985: First SRI Fellow, 1985 Annual Award for Outstanding Contributions to Health Psychology, American Psychological Association
• 1982: Annual Award for Outstanding Contributions to Health Psychology, American Psychological Association
• 1973: Sigma Xi
• 1971: Phi Beta Kappa
• 1971: Graduated Summa Cum Laude, Whitman College
Research Interests
• Principal Investigator: Clinical Trial of Coping Effectiveness Training. Clinical trial to investigate effectiveness of coping effectiveness training, including maintenance of effects and impact on positive affect and meaning of life. 1996-2003.
• Principal Investigator: Clinical Center for EXPLORE: A Randomized Clinical Trial of the Efficacy of a Behavioral Intervention to Prevent Acquisition of HIV. 1998-2004. Also Protocol Co-chair for EXPLORE Clinical Trial
• Principal Investigator: Health-related interventions for persons living with HIV. Multi-site interactive project to design and test an intervention to improve quality of life, adherence and reduce risk behaviors among HIV-infected men and women. 1998â?"2003.
• Co-Director: Center for AIDS Prevention Studies, A multi-disciplinary center focused on research to prevent the transmission and progression of HIV/AIDS, NIMH, 2001-2006.
• Associate Director: California AIDS Research Center: Center focused on exploring biomedical approaches to the prevention of HIV/AIDS. 2000-2006, State of California.
• Co-Principal Investigator: The Options Project: Primary HIV Infection: Epidemiology and Prevention, PI: Frederick Hecht, MD, CDC, 1996-2002, current year.
• Co- Investigator: Primary HIV Infection: Epidemiology and Prevention, and Immunologic and Virologic Features of Early HIV Infection, PI: Jay Levy, MD, NIAID, 1997-2002.
• Core Director: UCSF-Gladstone Immunology and Virology Center for AIDS Research. PIs: Paul Volberding, MD & Warner Greene, MD, 2002-2007. Behavioral and Epidemiology Core.
• Principal Investigator: Coping Effectiveness Training for HIV+ Men, Clinical trial of theory-based intervention designed to assist in coping with chronic illness. NIMH.
• Principal Investigator: Adherence in AIDS Clinical Trials, NIMH, Project within Center for AIDS Prevention Studies.
• Principal Investigator: Behavioral Interventions for Mild Essential Hypertension.
• Principal Investigator: Epidemiological Analysis of Type A Behavior, National Institute of Mental Health (NIMH).
• Principal Investigator: Women, Work and Health, NIMH.
• Principal Investigator: Cardiovascular Reactivity and Nonverbal Components of Type A Behavior.
• Principal Investigator: NHLBI Twin Study Follow-up Examination.
• Principal Investigator: Coronary Artery Risk Development in Young Adults (CARDIA) Assessment of the Type A Behavior Pattern, Kaiser-Permanente/NHLBI.
Publications
Selected Publications
Chesney, M.A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30 (Suppl 2), S171-S176
Chesney, M.A., Ickovics, J.R., Chambers, D.B., Gifford, A.L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care, 12 (3), 255-266.
Chesney, M.A., Morin, M., & Sherr, L. (2000). Adherence to HIV combination therapy. Social Science and Medicine, 50, 1599-1605.
Hecht, F.M., Chesney, M.A., Lehman J.S., Osmond, D., Vranizan, K., Colman, S., et al. (2000). Does HIV reporting by name deter testing? AIDS, 14, 1-8.
Anderson, D.E., Scuteri, A., Metter, J., & Chesney, M.A. (2001). Association of high resting end tidal CO2 with carotid artery thickness in women, not men. Journal of Hypertension, 19, 459-463.
Bangsberg, D.R., Hecht, F.M., Charlebois, E., Chesney M.A., & Moss A.R. (2001). Comparing objective methods of adherence assessment: electronic medication monitoring and unannounced pill count. AIDS and Behavior, 5, 275-281.
Anderson, D.E. & Chesney, M.A. (2001). Emotional inhibition, breath holding, and socium-sensitive hypertension in women. Primary Psychiatry, 8, 66-70
Kahn J.O., Martin J.N., Roland M.E., Bamberger J.D., Chesney M.A., Chambers D., et al. (2001). Feasibility of post-exposure prophylaxis against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study. Journal of Infectious Diseases, 183, 707-714.
Rosengard, C., Chambers, D., Tulsky, J.P., Long, H.L., & Chesney, M. (2001). Value on health, health concerns, and practices of women who are homeless. Women and Health, 34 (2), 29-44.
Scuteri, A., Parsons, D., Chesney, M.A., & Anderson, M.A. (2001). Anger inhibition potentiates the association of high end-tidal CO2 with blood pressure in women. Psychosomatic Medicine, 63, 470-475.
Wagner, J.H., Justice, A.C., Chesney, M., Sinclair, G., Weissman, S., & Rodriguez-Barradas, M. (2001). Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. Journal of Clinical Epidemiology, 54 (Suppl. 1), S91-98.
Cohn, S.E., Kammann, E., Williams, P., Currier, J.S., & Chesney, MA. (2002). Association of adherence to prophylaxis and antiretroviral therapy with clinical outcomes in AIDS. Clinical Infectious Diseases, 34, 8, 1129-36.
Bangsberg, D.B., Bronstone, A., Chesney, M.A. & Hecht, F.M. (2002). Computer Assisted Self Interviewing (CASI) to Improve Provider Assessment of Adherence in Routine Clinical Practice, JAIDS, 31 Suppl 3: S107-11
Hecht, F.M., Busch, M.P., Rawal, B., Webb, M., Rosenberg, E., Swanson, M., Chesney, M., et al. (2002). Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS, 16: 1119-1126
Whooley, M.A., Kiefe, C.I., Chesney, M.A., Markovitz, J.H., Matthews, K., Hulley, S.B. (2002). Depressive symptoms, unemployment, and loss of income: The CARDIA study. Archives of Internal Medicine, 162: 2614-2620
Lester, P., Chesney, M.A., Cooke, M., Weiss, R., Whalley, P., Perez, B., et al. (2002). When the time comes to talk about HIV: Factors associated with diagnostic disclosure and emotional distress in HIV-infected children. JAIDS, 31: 309-317.
Chesney, M. A. & Antoni, M. (2002). Co-Editors. Health Psychology Innovations: New Target Populations for Prevention and Care. Washington DC: APA.
Bouhnik, A.D., Chesney, M.A., Carrieri, P., Gallais, H, Moreau, J, Moatti, J.P., Obadia, Y., Spire, B. and the MANIF 2000 Group (2002) Nonadherence among HIV-infected injecting drug users: The impact of social instability. JAIDS, 31, S149-153.
Anderson, D.E. & Chesney, M.A. (2002) Gender-specific association of perceived stress with inhibited breathing pattern. International Journal of Behavioral Medicine. 9, 216-277.
Ickovics, JR., Cameron, A., Zackin, R., Bassett, R., Chesney, M, Johnson, VA. & Kuritzkes, DR for the ACTG 370 Protocol Team. (2002). Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult AIDS Clinical Trials Group Protocol 370. Antiretroviral Therapy; 7,185-9.
Carrieri, M.P., Chesney, M.A., Spire, B., Loundou, A., Sobel, A., Lepeu, G., et al. (2003) Failure to maintain adherence to HAART in a cohort of French HIV-infected injecting drug users. International Journal of Behavioral Medicine, 10, 1-14.
Chesney, M.A., Chambers, D.B., Taylor, J.M., & Johnson, L M., & Folkman, S. (2003) Coping Effectiveness Training for men living with HIV: Results from a randomized clinical trial testing a group-based intervention. Psychosomatic Medicine, 65, 1038-1046.
Chesney, M.A., Chambers, D.B., Taylor, J.M., & Johnson, L M. (2003). Social support, distress and well-being in older men living with HIV. JAIDS, 33(S2), S185-S193.
Chesney, M.A. & Coates, T.J. (2003). The evolution of HIV prevention in San Francisco: A multidisciplinary model. In F. Kessel, P. Rosenfield, & N. Anderson (Eds.). Expanding the Boundaries of Health and Social Science: Case Studies in Interdisciplinary Innovation. Oxford: Oxford University Press, 348-377.
Walsh, M.M., Hilton, J.F., Ellison, J.A., Gee, L., Chesney, M.A., Tomar, S.L., & Ernster V.L. (2003). Spit (Smokeless) Tobacco Intervention for High School Athletes: results after 1 year. Addictive Behavior, 28(6):1095-113.
Smith, S.R., Rublein, J.C., Marcus, C.M., Brock, T.P., & Chesney, M.A. (2003). A Medication Self-Management Program to Improve Adherence to HIV Therapy Regimens. Patient Education and Counseling, 50, 187-99.
Mellins, C.A., Kang, E., Leu, C., Havens, J.F. & Chesney, M.A. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17, 8, 407-416.
Koblin, B.A., Chesney, M.A., Husnik, M.J., Celum, C.L., Colfax, G., Mayer, K., McKirnan, D., Judson, F.N., Huang, Y., Coates, T.J. & the EXPLORE Study Team (2003) High-risk behaviors among men who have sex with men in 6 US cities: Baseline data from the EXPLORE Study. American Journal of Public Health, 93, 926-932.
Chesney, M. Adherence to HAART regimens. (2003) AIDS Patient Care and STDS, 17, 169-77.
Chesney, M.A., Koblin, B.A., Barresi, P.J., Husnik, M.H., Celum, D. L., Colfax, G., Mayer, K., McKirnan, D., Judson, F.N., Huang, Y., Coates, T.J., & the EXPLORE Study Team (2003) An individually-tailored intervention for HIV prevention: Baseline data from the EXPLORE Study. American Journal of Public Health, 93, 933-938
Orth-Gomer, K, Weidner, G. & Chesney, M.A. (2004) Psychosocial influences on the heart. In M.H. Crawford, J.P. DiMarco, & J.P. Walters (Eds) Cardiology, 2nd Ed., London: Elsevier. Pp. 1571-1576.
Tulsky, J.P., Hahn, J.A., Long, H.L., Chambers, D.B., Robertson, M.J., Chesney, M.A., & Moss, A.R. (2004). Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. International Journal of Tuberculosis and Lung Diseases, 8, 83-91.
EXPLORE Study Team. (2004) Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: The EXPLORE randomized controlled study. Lancet, 36, 41-50.
Reynolds, N.R., Testa, M.A., Marc, L.G., Chesney, M.A., Neidig, J.L., Smith, S.R., Vella, S., Robbins, G.K. for the Protocol Teams of ACTG 384, ACTG 731 and A5031s (2004). Factors influencing medication adherence beliefs and self-efficacy in persons naïve to antiretroviral therapy: A multi-center, cross-sectional study. AIDS and Behavior, 8, 141-150.
Chesney, M.A. & Straus, S.E. (2004) Complementary and Alternative Medicine: The Convergence of Public Interest and Science in the United States. Medical Journal of Australia, 181, 335-36.
Straus, S.E. & Chesney, M.A. (2004) NCCAM: A new plan, new priorities, and an open invitation. Alternative Therapies in Health and Medicine, 10: 16
Lane, R.D., Lauker, C., Marcus, F.K., Chesney, M.A., Sechrist, L., Gear, K., Fort, C.L., Prioir, S.G., Schwartz, P.J., & Steptoe, A. (2005) Psychological stress preceding idiopathic ventricular fibrillation. Psychosomatic Medicine, 67, 359-365.
Chesney, M.A., Darbes, L., Hoerster, K., Taylor, J., Chambers, D.C., & Anderson, D.E. (2005) Positive emotions: The other hemisphere of behavioral medicine. International Journal of Behavioral Medicine, 12, 50-58
Berman, J. & Chesney, M.A. (2005). Complementary and alternative medicine in 2006: Optimizing the dose of the intervention. Medical Journal of Australia, 183: 574-5.
Nahin, R.L., Pontzer, C.H., & Chesney, M.A. (2005) Racing toward the integration of complementary and alternative medicine: A marathon or a sprint? Health Affairs, 24, 991-993.
Ashton, E., Vosvick, M., Chesney, M., Gore-Felton, C., Koopman, C., O’Shea, K., Maldonado, J., Bachmann, M., Israelski, D., Flamm, J., & Spiegel, D. (2005). Social support and dysfunctional coping as predictors of change in physical health symptoms among persons with HIV/AIDS. AIDS Patient Care and STDs, 19, 587-598.
Fletcher, C.V., Testa, M.A., Brundage, R.C., Chesney, M.A., Haubrich, R., Acosta, E.P., Martinez, A., Jiang, H., & Gulick RM. (2005). Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. JAIDS, 40: 301-6.
Collier, A.C., Ribaudo, H., Feinberg, J., Fischl, M.A., Chesney, M.A., Adult AIDS Clinical Trials Group 746 Substudy Team. (2005) A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. Journal of Infectious Diseases, 192, 1398-406
Roland, M.E., Neilands, R.B., Krone, M.R., Katz, M.H., Chesney, M.A., and Martin, J.N. (2005). Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clinical Infectious Diseases, 41:1507-13.
Johnson, M.O., Elliott, T. R., Neilands, T. B., Morin, S. F., & Chesney, M.A. (2006). A Social Problem Solving Model of Adherence to HIV Medications. Health Psychology, 25:355-63.
Mansky, P., Sannes, T., Wallerstedt, D., Ge, A., Ryan, M., Johnson, L.L., Chesney, M.A., & Gerber, L. (2006) Tai chi chuan: Mind body practice or exercise intervention? Studying the benefit for cancer survivors. Integrative Cancer Therapy, 5:192-201
Johnson, M.O., Chesney, M.A., Goldstein, R.B., Remien, R.H., Catz, S., Gore-Felton, C, & Charlebois, E. (2006) Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care and STDS, 20, 258-268.
Johnson, M.O., & Chesney, M.A. (2006). The value and challenges of improving adherence to antiretroviral therapy for HIV. Medical Care, 44(10):891-2.
Chesney, M.A. The elusive gold standard: Future Perspectives for HIV Adherence Assessment and Intervention. (2006). Journal of Acquired Immune Deficiency Syndrome, 43 Suppl 1:S149-55.
Chesney, M.A., Neilands, T.B., Chambers, D.B., Taylor, J.M., Folkman S. (2006) A validity and reliability study of the coping self-efficacy scale. British Journal of Health Psychology, 11: 421-37
Straus, S.E. & Chesney, M.A. (2006). In defense of NCCAM. Science, 313: 303-4.
Pearson, N.J. & Chesney, M.A. (2007).The CAM Education Program for the National Center for Complementary and Alternative Medicine: An Overview. Academic Medicine, 82:921-926.
Johnson, M.O., Neilands, T.B., Dilworth, S., Morin, S.F., Remien, R.H., & Chesney, M.A. (2007). The role of self-efficacy in HIV treatment adherence: Validation of the HIV treatment adherence self-efficacy scale (HIV-ASES). Journal of Behavioral Medicine, 30(5):359-70.
Johnson, M.O., Charlebois, E., Morin, S.F., Remien, R.H., Chesney, M.A. and The Healthy Living Project. (2007). Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: The Healthy Living Project randomized controlled study. JAIDS, 46(5):574-80
Reynolds, N.R., Sun, J., Nagaraja, H.N., Gifford, A., Wu, A., Chesney, M.A. (2007).Optimizing measurement of self-reported adherence with the AIDS Clinical Trials Group Adherence Questionnaire: A cross-protocol analysis. JAIDS, 46(4):402-9.
Nahin, R.L., Dahlhamer, J.M., Taylor, B.L., Barnes, P.M., Stussman, B.J., Simile, C.M., Blackman, M.R., Chesney, M.A., Jackson, M., Miller, H., & McFann, K.K. (2007). Health behaviors and risk factors in those who use complementary and alternative medicine. BMC Public Health, 7(147):217.
.
Reynolds, N.R., Testa, M.A., Su, M., Chesney, M.A., Neidig, J.L., Frank, I., Smith, S., Ickovics, J., Robbins, G.K., for the AIDS Clinical Trails Group 731 and 384 Teams. (2008) Telephone support to improve antiretroviral medication adherence: A multisite, randomized controlled trial. Journal of Acquired Immune Deficiency Syndrome, 47: 62-68.
Mannheimer, S, Thackeray, L, Hullsiek, K.H., Chesney, M.A. Gardner, E.M., Wu, A.W., Telzak, E.E., Lawrence, J, Baxter, J, Friedland, G. for the Terry Beirn Community Program for Clinical Research on AIDS (CPCRA) (2008) A Randomized Comparison of Two Instruments for Measuring Self-Reported Antiretroviral Adherence. AIDS Care, 2:161-9.
Cohn, S., Umbleja, T., Mrus, J., Bardeguez, A.D., Anderson, J, & Chesney, M.A. (2008). Prior illicit drug use and missed prenatal vitamins predict non-adherence to antiretroviral therapy in pregnancy: Adherence Analysis of A5084. AIDS Patient Care and STDs, 22(1):29-40
Johnson, M.O., Dilworth, S.E., Neilands, T.B., Chesney, M.A., Rotheram-Borus, M.J., Remien, R.H., Weinhardt, L.S., Ehrhardt, A.A., & Morin, S.F. Predictors of Attrition among High Risk HIV-Infected Participants Enrolled in a Multi-Site Prevention Trial. AIDS & Behavior, in press.
Mannheimer, S., Matts, J., Gardner, E.M., Telzak, E.E., Child, D., Wu, A.W., Chesney, M.A.. & Friedland, G. (2008) Mild-to-Moderate symptoms worsen quality of life in HIV-infected individuals. Clinical Infectious Diseases, 46(6):941-5.
Mellins, C.A., Havens, J.F., McDonnell, C., Lichtenstein, C., Uldall, K., Chesney, M.A.,Santamaria, E.K. & Bell, J. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance use disorders. AIDS Care, in press
Carrico, A.W., Chesney, M.A., Johnson, M.O., Morin, S.F., Neilands, T.B., Remien, R.H., Rotheram-Borus, M.J., Wong, F.L. & The NIMH Healthy Living Project Team. Randomized controlled trial of a cognitive-behavioral intervention for HIV-positive persons: An investigation of treatment effects on psychosocial adjustment. AIDS and Behavior, in press.
Faculty members:
Click here to update your contact information and create a profile.
|